Growth Metrics

Artivion (AORT) Acquisitions (2012 - 2020)

Artivion posted quarterly Acquisitions of -$524000.0 for Q4 2020, up 99.42% on a QoQ basis from -$89.9 million in Q4 2016.

Artivion (AORT) has 3 years of Acquisitions data on file, last reported at -$524000.0 in Q4 2020.

  • For the quarter ending Q4 2020, Acquisitions changed N/A year-over-year to -$524000.0; the trailing twelve-month figure through Dec 2020 stood at -$90.4 million (changed N/A YoY), and the FY2020 full-year result was $59.1 million, changed N/A from the prior year.
  • Acquisitions for Q4 2020 stood at -$524000.0, up from -$89.9 million in the prior quarter.
  • Across five years, Acquisitions topped out at $91.2 million in Q1 2016 and bottomed at -$89.9 million in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 22.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Artivion 1.02 Bn 961.00 Mn 75.45 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 -524,000.00
Dec 31, 2016 -89.93 Mn
Sep 30, 2016 89.93 Mn
Jun 30, 2016 -89.93 Mn
Mar 31, 2016 91.15 Mn
Sep 30, 2012 -15,000.00